TrademarkDir
EVERNORTH
LIVE

Serial Number

88945497

Owner

EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC.

Attorney

Dennis S. Prahl

First Use Date

Feb 7, 2024

Filing Date

Jun 3, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EVERNORTH Trademark

Serial Number: 88945497 • Registration: 7482446

EVERNORTH is a trademark filed by EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. on June 3, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. (287 trademarks)

ONE EXPRESS WAY
ST. LOUIS, MO 63121

Entity Type: 03

Trademark Details

Filing Date

June 3, 2020

Registration Date

August 20, 2024

First Use Anywhere

February 7, 2024

First Use in Commerce

February 7, 2024

Published for Opposition

March 9, 2021

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 20, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 20, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 12, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 12, 2024 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2024 CRFA
ASSIGNED TO LIE
Jun 20, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 11, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 30, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 30, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Apr 30, 2024 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Apr 8, 2024 SUPC
USE AMENDMENT FILED
Apr 4, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 4, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 28, 2023 EXRA
SOU EXTENSION 5 GRANTED
Oct 27, 2023 EX5G
SOU EXTENSION 5 FILED
Oct 24, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Oct 24, 2023 EEXT
CORRECTED NOA E-MAILED
May 27, 2023 NOAC
DIVISIONAL PROCESSING COMPLETE
May 26, 2023 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 23, 2023 AITU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 5, 2023 EXRA
DIVISIONAL REQUEST RECEIVED
May 4, 2023 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
May 4, 2023 ERTD
SOU EXTENSION 4 GRANTED
May 3, 2023 EX4G
SOU EXTENSION 4 FILED
May 3, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
May 3, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 3, 2022 EXRA
SOU EXTENSION 3 GRANTED
Nov 1, 2022 EX3G
SOU EXTENSION 3 FILED
Nov 1, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 1, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 5, 2022 EXRA
SOU EXTENSION 2 GRANTED
May 3, 2022 EX2G
SOU EXTENSION 2 FILED
May 3, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
May 3, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 28, 2021 EXRA
SOU EXTENSION 1 GRANTED
Oct 26, 2021 EX1G
SOU EXTENSION 1 FILED
Oct 26, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 26, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 4, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 9, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 28, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 27, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 27, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 27, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 27, 2021 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 14, 2020 GNRN
NON-FINAL ACTION E-MAILED
Sep 14, 2020 GNRT
NON-FINAL ACTION WRITTEN
Sep 14, 2020 CNRT
ASSIGNED TO EXAMINER
Sep 4, 2020 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Aug 24, 2020 AMPX
ASSIGNED TO LIE
Aug 16, 2020 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Jul 28, 2020 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 24, 2020 NWOS
NEW APPLICATION ENTERED
Jun 6, 2020 NWAP

Related Trademarks

More from this Owner

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EXPRESS SCRIPTS PHARMACY CLEARCHOICE PRICING

EXPRESS SCRIPTS PHARMACY CLEARCHOICE PRICING

EXPRESS SCRIPTS PHARMACY CLEARCHOICE PRICING

EXPRESS SCRIPTS PHARMACY CLEARCHOICE PRICING

ONCOLOGY CARE VALUE

ONCOLOGY CARE VALUE